Glatiramer-5001
Recruitment Complete
Copaxone Subcutaneous Injection Syringe Special Drug Use-Result Investigation (All-Case Investigation) "Prevention of Relapse of Multiple Sclerosis"
About this clinical trial
The purpose of this study is to evaluate the safety and efficacy of Copaxone subcutaneous injection syringe (hereinafter referred to as Copaxone) in patients with multiple sclerosis in the routine clinical setting.
JP
Observational clinical trial.
At a glance
What medical conditions were being studied?
Multiple Sclerosis (MS)
What was the clinical trial testing?
Glatiramer acetate
How many participants were enrolled?
1332
When was the clinical trial conducted?
Nov 2015 - Mar 2024
Key requirements
Sex
All
Age
All
Healthy volunteers?
No
Inclusion Criteria:
- All patients treated with Copaxone from the first day of market launch of the product
Exclusion Criteria:
-None